CPH Global Medical ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 38.6% 32.7% 17.5%  
Credit score (0-100)  0 0 0 0 8  
Credit rating  N/A N/A C C B  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -936 -2,327 -347  
EBITDA  0.0 0.0 -1,715 -2,767 -334  
EBIT  0.0 0.0 -1,815 -2,866 -393  
Pre-tax profit (PTP)  0.0 0.0 -1,864.8 -2,945.1 -674.6  
Net earnings  0.0 0.0 -1,864.8 -2,945.1 -674.6  
Pre-tax profit without non-rec. items  0.0 0.0 -1,865 -2,945 -675  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 199 99.4 39.8  
Shareholders equity total  0.0 0.0 -1,825 -4,770 -5,445  
Interest-bearing liabilities  0.0 0.0 645 761 804  
Balance sheet total (assets)  0.0 0.0 4,561 1,162 584  

Net Debt  0.0 0.0 569 742 803  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -936 -2,327 -347  
Gross profit growth  0.0% 0.0% 0.0% -148.7% 85.1%  
Employees  0 0 3 1 0  
Employee growth %  0.0% 0.0% 0.0% -66.7% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 4,561 1,162 584  
Balance sheet change%  0.0% 0.0% 0.0% -74.5% -49.7%  
Added value  0.0 0.0 -1,715.5 -2,767.1 -333.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 99 -199 -119  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 193.9% 123.2% 113.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -28.4% -46.6% -6.6%  
ROI %  0.0% 0.0% -281.1% -408.2% -50.2%  
ROE %  0.0% 0.0% -40.9% -102.9% -77.3%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% -28.6% -80.4% -90.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -33.2% -26.8% -240.9%  
Gearing %  0.0% 0.0% -35.3% -16.0% -14.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 16.4% 10.8% 36.0%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.3 0.0 0.0  
Current Ratio  0.0 0.0 0.7 0.2 0.1  
Cash and cash equivalent  0.0 0.0 75.8 18.8 0.6  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -2,023.6 -4,869.3 -5,484.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -572 -2,767 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -572 -2,767 0  
EBIT / employee  0 0 -605 -2,866 0  
Net earnings / employee  0 0 -622 -2,945 0